ES2195798T1 - Formulacion para mujeres menopausicas. - Google Patents

Formulacion para mujeres menopausicas.

Info

Publication number
ES2195798T1
ES2195798T1 ES00957857T ES00957857T ES2195798T1 ES 2195798 T1 ES2195798 T1 ES 2195798T1 ES 00957857 T ES00957857 T ES 00957857T ES 00957857 T ES00957857 T ES 00957857T ES 2195798 T1 ES2195798 T1 ES 2195798T1
Authority
ES
Spain
Prior art keywords
compound
formulation
fatty acid
omega
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES00957857T
Other languages
English (en)
Other versions
ES2195798T3 (es
Inventor
R Saul Levinson
Marc S Hermelin
Mitchell I Kirschner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amag Pharma USA Inc
Original Assignee
Drugtech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drugtech Corp filed Critical Drugtech Corp
Publication of ES2195798T1 publication Critical patent/ES2195798T1/es
Application granted granted Critical
Publication of ES2195798T3 publication Critical patent/ES2195798T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)

Abstract

Una composición para la administración a mujeres premenopáusicas y menopáusicas, que comprende: un compuesto de ácido graso esencial, que se selecciona entre el conjunto que consta de un compuesto de ácido linoleico, un compuesto de ácido linolénico, un compuesto de ácido docosahexaenoico, un compuesto de ácido graso omega-3, un compuesto de ácido graso omega-2, uno de sus derivados y una de sus combinaciones en una cantidad de aproximadamente 10 mg a aproximadamente 1.000 mg; un compuesto de calcio o uno de sus derivados en una
ES00957857T 1999-09-30 2000-08-28 Formulacion para mujeres menopausicas antecedentes de la invencion. Expired - Lifetime ES2195798T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US409059 1989-09-19
US09/409,059 US6479545B1 (en) 1999-09-30 1999-09-30 Formulation for menopausal women

Publications (2)

Publication Number Publication Date
ES2195798T1 true ES2195798T1 (es) 2003-12-16
ES2195798T3 ES2195798T3 (es) 2007-11-16

Family

ID=23618887

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00957857T Expired - Lifetime ES2195798T3 (es) 1999-09-30 2000-08-28 Formulacion para mujeres menopausicas antecedentes de la invencion.

Country Status (14)

Country Link
US (5) US6479545B1 (es)
EP (1) EP1216024B1 (es)
JP (1) JP2003510344A (es)
KR (1) KR100831511B1 (es)
CN (1) CN1391464A (es)
AT (1) ATE357213T1 (es)
AU (1) AU778507B2 (es)
BR (1) BR0014438A (es)
CA (2) CA2645397A1 (es)
DE (2) DE00957857T1 (es)
ES (1) ES2195798T3 (es)
MX (1) MXPA02003101A (es)
WO (1) WO2001024772A1 (es)
ZA (1) ZA200202633B (es)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0862445B2 (en) * 1995-10-06 2017-03-22 Arch Development Corporation Combination of herpes simplex virus and chemotherapy for treating cancer
US6642259B1 (en) * 1999-05-07 2003-11-04 Trustees Of Tufts College Immune stimulating dietary supplement and method of use thereof
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
MXPA03004817A (es) * 2000-11-29 2003-09-10 Smithkline Beecham Corp Composicion dietetica conteniendo acido linoleico conjugado y calcio para salud mejorada.
IL157944A0 (en) * 2001-03-16 2004-03-28 Wyeth Corp Hormone replacement therapy
AT411327B (de) * 2001-08-23 2003-12-29 Heil Bettina Hormonpräparat mit ungesättigten fettsäuren
US7704542B2 (en) * 2001-09-12 2010-04-27 Xanodyne Pharmaceuticals, Inc. Vitamin/mineral compositions with DHA
US6911438B2 (en) * 2001-09-12 2005-06-28 Jonathan V. Wright Hormone replacement formulation
NL1019368C2 (nl) 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
US6821532B2 (en) * 2001-11-16 2004-11-23 Unitel Technologies, Inc. Methods and compositions for the treatment of benign prostatic hypertrophy
PL209558B1 (pl) * 2002-02-21 2011-09-30 Bayer Schering Pharma Ag Zestaw zawierający steroid, składnik tetrahydrofolianowy i witaminę B12 do zastosowania w metodzie hormonalnej antykoncepcji lub hormonalnej terapii zastępczej
WO2003082339A1 (en) * 2002-03-22 2003-10-09 Doc's Guide, Inc. Multivitamin and mineral nutritional supplement
US6610331B1 (en) * 2002-05-30 2003-08-26 Scott M. Sweazy Fertility kit
EP1517667A2 (en) * 2002-07-02 2005-03-30 Galileo Pharmaceuticals, Inc. Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
US20060094785A1 (en) * 2002-07-12 2006-05-04 Guttuso Jr Thomas J Use of amino acids for treatment of various conditions
WO2004028470A2 (en) 2002-09-27 2004-04-08 Martek Biosciences Corporation Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation
US20050064013A1 (en) * 2002-10-11 2005-03-24 Jeffrey Liebrech Ready to drink beverage composition having liquid form HGH pre-cursor and method of making same
GB0228571D0 (en) * 2002-12-06 2003-01-15 Novartis Ag Organic compounds
TWI322691B (en) 2003-04-11 2010-04-01 Follicle-stimulating hormone reducing agent
US20040253319A1 (en) * 2003-06-11 2004-12-16 Shrirang Netke Pharmaceutical compositions and method for alleviating side-effects of estrogen replacement therapy
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
US7857913B2 (en) * 2003-06-26 2010-12-28 Spindler William E Cleaning compound for cleaning surfaces in a food processing environment
US20050032740A1 (en) * 2003-08-06 2005-02-10 Balaji Venkataraman Vitamin compositions for the treatment and prevention of vascular disease and dementia
US20050032741A1 (en) * 2003-08-06 2005-02-10 Balaji Venkataraman Vitamin Compositions
JP2005075804A (ja) * 2003-09-03 2005-03-24 Toyo Capsule Kk メナテトレノン含有医薬組成物
US7875291B1 (en) 2003-09-05 2011-01-25 Glu-Pro, Inc. Composition for managing diabetes, obesity, and hyperlipidemia and associated methods
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
JP2007505927A (ja) 2003-09-19 2007-03-15 ドラッグテック コーポレイション 薬物送達システム
US20050112215A1 (en) * 2003-10-09 2005-05-26 Valerie Otto Cramp bark extract and method of extraction
US20050158404A1 (en) * 2003-11-18 2005-07-21 Goodless Dean R. Composition and method for treatment of acne
US20050202038A1 (en) * 2004-03-10 2005-09-15 Green Roger E. Composition and method for minimizing residual fecal matter in the perianal area
CA2563237C (en) * 2004-04-07 2012-10-09 Rutgers, The State University Of New Jersey Appetite-suppressing compositions and methods
GB2414181A (en) * 2004-05-19 2005-11-23 Merck & Co Inc compositions containing a bisphosphonate and a Vitamin D derivative
US20050266130A1 (en) * 2004-05-28 2005-12-01 Henry Aoki Method for solidification and storing of components extracted from plant, animal, or mineral matter and extract components extracted from held plant, animal, or mineral matter
US20060039971A1 (en) * 2004-08-19 2006-02-23 Lee Robert E Effervescent composition including alternative hormone replacement therapy agent
US20060135610A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Cardiovascular compositions
JP2008540534A (ja) * 2005-05-09 2008-11-20 ドラッグテック コーポレイション 放出調節薬学組成物
UY29527A1 (es) 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
JP2007023010A (ja) * 2005-07-19 2007-02-01 Toshiro Azegami 閉経後のホルモンバランス調整及びパーキンソン症の予防改善目的の経口組成物
US7901710B2 (en) 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8202546B2 (en) 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8263137B2 (en) 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US7998500B2 (en) 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US20070048367A1 (en) * 2005-08-31 2007-03-01 Mom Enterprises, Inc. Herbal composition for treating morning sickness
US20070122460A1 (en) * 2005-11-28 2007-05-31 Yvonne Daily Hot-flash wipes and clothing
CN101365425A (zh) * 2006-01-05 2009-02-11 药物技术公司 用于生物粘附到外阴***表面的递药***
EA200870153A1 (ru) * 2006-01-05 2008-12-30 Драгтек Корпорейшн Композиция и способ ее использования
JP2009523831A (ja) * 2006-01-20 2009-06-25 ペア トゥリー ファーマシューティカルズ インコーポレイテッド 萎縮性膣炎を治療する方法
US9693953B2 (en) 2006-06-02 2017-07-04 Janet A. Chollet Method of treating atrophic vaginitis
US20080057144A1 (en) * 2006-09-01 2008-03-06 Cathy Beggan Wake up on time dietary supplement and method of use
US20080138383A1 (en) * 2006-12-07 2008-06-12 Jonathan David Bortz Compositions and methods for treating seizures
US20080241290A1 (en) * 2007-03-30 2008-10-02 Wayne Jeffrey Perry Sinus relief composition and method of producing the same
US20080242741A1 (en) * 2007-03-30 2008-10-02 Wayne Jeffrey Perry Intranasal drug delivery system
US20130115320A1 (en) 2007-03-30 2013-05-09 Dynova Laboratories, Inc. Therapeutic agent for intranasal administration and method of making and using same
JP5374491B2 (ja) * 2007-04-02 2013-12-25 アビラ，アルフレド 骨折および骨欠損の処置のためのハーブ製剤
US20090053319A1 (en) * 2007-08-21 2009-02-26 Wayne Jeffrey Perry Sore Throat Relief Composition And Method of Producing Same
US20090069446A1 (en) * 2007-09-06 2009-03-12 Wayne Jeffrey Perry Dendritic salt therapeutic agent delivery system
US20090069433A1 (en) * 2007-09-10 2009-03-12 Wayne Jeffrey Perry Nasal rinse additive
US7964189B1 (en) 2007-09-25 2011-06-21 Argent Development Group, Llc Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women
US9125844B1 (en) 2007-09-25 2015-09-08 Argent Development Group, Llc Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women
UY31410A1 (es) * 2007-10-30 2009-05-29 Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado
US7824716B1 (en) * 2008-04-11 2010-11-02 Van De Pol Sylvia Herbal women's health formula
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
US8535660B1 (en) 2008-05-27 2013-09-17 Argent Development Group, Llc Nutritional supplements for pregnant women
US8535659B1 (en) 2008-05-27 2013-09-17 Argent Development Group, Llc Nutritional supplements for pregnant women
US20100040708A1 (en) * 2008-08-13 2010-02-18 Vicki Boynton Herbal composition
US20100255147A1 (en) * 2009-03-20 2010-10-07 Milk Specialties Company Non-Settling Galacto-Oligosaccharide-Rich Liquid Concentrate and Related Methods and Nutritional Compositions
IT1397405B1 (it) * 2009-06-23 2013-01-10 A M S A S R L Formulazione integrativa finalizzata al controllo delle alterazioni organiche multifattoriali ricorrenti nel periodo della menopausa
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CN105611926A (zh) * 2013-10-09 2016-05-25 味之素株式会社 抗疲劳组合物
KR101400913B1 (ko) * 2014-03-12 2014-05-28 주식회사 파미니티 여성 호르몬 조절질환의 예방, 치료 또는 개선용 약학 조성물 및 식품용 조성물
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
US9392814B2 (en) * 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
CN104027339B (zh) * 2014-06-12 2017-01-18 王淑芳 一种维生素组合物及其调理卵巢功能应用
AU2015296609A1 (en) 2014-07-29 2016-12-22 Therapeuticsmd, Inc. Transdermal cream
AU2016207821A1 (en) * 2015-01-14 2017-07-13 Pf Consumer Healthcare 1 Llc Oral delivery product
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
BR112018070199A2 (pt) 2016-04-01 2019-01-29 Therapeuticsmd Inc composição farmacêutica de hormônio esteroide
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CN105944088A (zh) * 2016-06-29 2016-09-21 中国人民解放军第三军医大学第附属医院 用于调节卵巢功能的组合物及其应用
US10357529B2 (en) * 2016-11-07 2019-07-23 Rvrs, Llc Natural formulation for treating hangover
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US471387A (en) * 1892-03-22 Photographic album
NL8403433A (nl) * 1984-11-09 1986-06-02 Holland Melkunie Voedingssuppletiepreparaat op basis van melkbestanddelen.
GB8524276D0 (en) 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
US4752479A (en) * 1986-05-27 1988-06-21 Ciba-Geigy Corporaton Multi vitamin and mineral dietary supplement with controlled release bioavailable iron
GB8621816D0 (en) * 1986-09-10 1986-10-15 Efamol Ltd Therapeutic composition
US4851431A (en) * 1986-11-26 1989-07-25 Bar Ilan University Physiologically active and nutritional composition
US4900734A (en) 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
ATE130036T1 (de) 1987-10-14 1995-11-15 Kao Corp Verfahren zur herstellung eines polyol- fettsäureesters und dadurch erhaltene glyceridmischung.
IL91802A (en) * 1988-10-27 1994-05-30 Univ Bar Ilan Preparations containing linoleic acid history for the treatment of Alzheimer's, similar brain diseases, and epilepsy
US5012761A (en) * 1988-11-17 1991-05-07 Oh Suk Y Chicken egg having relatively high percentage of long chain fatty acids and method of reducing heart related disease in humans using such eggs
US4945103A (en) 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
US5514392A (en) * 1989-08-30 1996-05-07 Seawell Corporation N.V. Packaging for perishable goods
GB9112052D0 (en) * 1991-06-05 1991-07-24 Efamol Holdings Fatty acid treatment
US5670201A (en) * 1991-06-21 1997-09-23 Snow Brand Milk Co., Ltd. Low allergenic nutrient composition and method of using same
US5087586A (en) * 1991-07-03 1992-02-11 Micron Technology, Inc. Process for creating fully-recessed field isolation regions by oxidizing a selectively-grown epitaxial silicon layer
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
GB9211229D0 (en) 1992-05-27 1992-07-08 Efamol Holdings Fatty acid treatment
GB9217780D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
AU5162793A (en) 1992-09-23 1994-04-12 Kv Pharmaceutical Corporation Multi-vitamin and mineral supplement for pregnant women
EP0675725B1 (en) * 1992-12-23 2002-01-30 Abbott Laboratories Medical foods for the nutritional support of infant/toddler metabolic diseases
US5576666A (en) * 1993-11-12 1996-11-19 Nippondenso Technical Center Usa, Inc. Fractional-N frequency synthesizer with temperature compensation
US5484623A (en) * 1994-01-10 1996-01-16 Mclean; Linsey Dietary system high in oil intake for the treatment of obesity and for the lowering of saturated fats
US5855949A (en) * 1994-01-10 1999-01-05 Mclean; Linsey Dietary system high in oil intake
US5869084A (en) 1994-06-20 1999-02-09 K-V Pharmaceuticals Co. Multi-vitamin and mineral supplements for women
EP0707850A1 (en) * 1994-09-21 1996-04-24 Scotia Holdings Plc Use of polyunsaturated fatty acids for the manufacture of a medicament for the treatment of brest pain
US5514382A (en) 1994-10-17 1996-05-07 Sultenfuss; Sherry Daily vitamin and mineral supplement for women
US5589468A (en) * 1995-01-13 1996-12-31 Clintec Nutrition Co. Method for providing nutrition to elderly patients
US5569459A (en) 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
US5514328A (en) 1995-05-12 1996-05-07 Stoody Deloro Stellite, Inc. Cavitation erosion resistent steel
GB9510636D0 (en) * 1995-05-25 1995-07-19 Scotia Holdings Plc Fatty acid treatment
ATE262799T1 (de) * 1996-01-31 2004-04-15 Univ South Alabama Lebensmittel und vitamin herstellungen mit natürlichem isomeren von reduzierten folaten
US5807586A (en) 1996-07-30 1998-09-15 Energetics, Inc. Method of dietary supplementation
JP2002514170A (ja) * 1996-07-30 2002-05-14 エナージェティクス，インコーポレイティド 食品補充物
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
US5922704A (en) * 1997-12-24 1999-07-13 Feeling Fine Company Llc Optimal nutritional supplement for men
US6048846A (en) 1998-02-26 2000-04-11 Cochran; Timothy M. Compositions used in human treatment
AU4573899A (en) 1998-06-19 2000-01-05 Beth Israel Deaconess Medical Center Dietary supplement for post-menopausal women
US6569857B1 (en) * 1999-05-03 2003-05-27 Drugtech Corporation Dietary supplement
US6258846B1 (en) * 1999-06-01 2001-07-10 Drugtech Corporation Nutritional supplements
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
JP2008056612A (ja) 2006-08-31 2008-03-13 Koei Chem Co Ltd アミノピリジン類の製造方法

Also Published As

Publication number Publication date
MXPA02003101A (es) 2003-08-20
DE00957857T1 (de) 2005-03-31
DE60034046T2 (de) 2007-12-06
US7687485B2 (en) 2010-03-30
EP1216024A1 (en) 2002-06-26
ATE357213T1 (de) 2007-04-15
CN1391464A (zh) 2003-01-15
ZA200202633B (en) 2003-04-30
AU778507B2 (en) 2004-12-09
KR20020048424A (ko) 2002-06-22
EP1216024B1 (en) 2007-03-21
US20020137749A1 (en) 2002-09-26
KR100831511B1 (ko) 2008-05-22
ES2195798T3 (es) 2007-11-16
WO2001024772A1 (en) 2001-04-12
CA2385854C (en) 2005-04-12
US6479545B1 (en) 2002-11-12
US20090068289A1 (en) 2009-03-12
CA2645397A1 (en) 2001-04-12
BR0014438A (pt) 2002-08-20
JP2003510344A (ja) 2003-03-18
AU6941600A (en) 2001-05-10
EP1216024A4 (en) 2005-02-02
CA2385854A1 (en) 2001-04-12
US20050106266A1 (en) 2005-05-19
DE60034046D1 (de) 2007-05-03
US20020173510A1 (en) 2002-11-21

Similar Documents

Publication Publication Date Title
ES2195798T1 (es) Formulacion para mujeres menopausicas.
MXPA06008352A (es) Una composicion farmaceutica.
AR117404A2 (es) Unidad de dosificación que comprende un análogo de prostaglandina para el tratamiento de la constipación
ES2174814T3 (es) Acidos grasos esenciales destinados en la prevencion de accidentes cardio-vasculares.
BR0009373A (pt) Composições farmacêuticas orais contendo triglicerìdeos de cadeia longa e surfatantes lipofìlicos
IS5017A (is) Lyfjasamsetning sem inniheldur eikósapentaensýru og/eða stearidónsýru
ATE207346T1 (de) Orale pharmazeutische zusammensetzungen mit sexualhormonen
AR037081A1 (es) Composicion para el suministro transdermico de fentanilo
ECSP045305A (es) Composiciones farmacéuticas que comprenden uno o varios esteroides, uno o varios componentes tetrahidrofolatos y vitamina b12
AR030891A1 (es) Un metodo para suprimir el mal olor bucal y proporcionar proteccion de larga duracion contra el mal aliento en la cavidad oral
HRP20010615B1 (en) Pharmaceutical compositions containing proton pump inhibitors
TW200531696A (en) Pharmaceutical formulations of bisphosphonates
HUP0202342A2 (hu) Esszenciális zsírsavakat és homociszteinszint csökkentő hatóanyagokat tartalmazó gyógyászati és élelmiszer-készítmények
PH12017502416A1 (en) 17-hydroxyprogesterone ester-containing oral compositions and related methods
UY26303A1 (es) Composiciones farmacéuticas para administración oral y tópica
DK0623019T3 (da) Medikamenter på basis af docosahexaensyre som midler mod blodpladeaggregation og mod cerebral mangel på essentielle fedtsyr
DE60003537D1 (de) Zusammensetzungen enthaltend boswellia-extrakte
CO5160323A1 (es) Formulaciones farmaceuticas mejoradas vir en combinacion con otros inhibidores de proteasa vih
PE20050138A1 (es) Aceites de pescado con un perfil alterado de acidos grasos, un metodo para producir esos aceites y uso de ellos
ES2140512T3 (es) Composiciones farmaceuticas que contienen derivados de estaurosporina y un gliceridos polialquilenglicolico.
DK1227814T3 (da) Hormonal sammensætning baseret på nomegestrolacetat og et östrogen samt anvendelse heraf
NO20024796L (no) Preparater for anvendelse som penetrasjonsfremmere i transdermale formuleringer for meget lipofile aktive bestanddeler
CO4790151A1 (es) COMPOSICIONES QUE COMPRENDEN UN INHIBIDOR DE LA PROTEASA DEL VIH COMO VX478 Y UN COMPUESTO DE VITAMINA E sOLUBLE EN AGUA COMO VITAMINA E - TPGS
SE0201566D0 (sv) New composition
NO20014341L (no) Opplösning av flerumettede fettsyrer og derivater derav ved dannelse av inklusjonssammensetninger med <gamma>-syklodekstrin ogbruk derav i farmasöytiske, kosmetiske eller matsammensetninger